| Literature DB >> 24271120 |
Abstract
This review describes the design and current development of leukotriene biosynthesis inhibitors as potential antiinflammatory agents. Knowledge of the enzymatic mechanism of 5-lipoxygenase led to specific inhibitors of this enzyme which catalyzes a key step in the leukotriene pathway. Competitive inhibitors include iron chelators, redox agents and alternate substrates. Further, the potential of product inhibitors and mechanism based inactivators of 5-lipoxygenase is discussed.Entities:
Year: 1985 PMID: 24271120 DOI: 10.1023/A:1016381215385
Source DB: PubMed Journal: Pharm Res ISSN: 0724-8741 Impact factor: 4.200